These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 28790340)

  • 21. TAZ and YAP are frequently activated oncoproteins in sarcomas.
    Fullenkamp CA; Hall SL; Jaber OI; Pakalniskis BL; Savage EC; Savage JM; Ofori-Amanfo GK; Lambertz AM; Ivins SD; Stipp CS; Miller BJ; Milhem MM; Tanas MR
    Oncotarget; 2016 May; 7(21):30094-108. PubMed ID: 27129148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell competition in mouse NIH3T3 embryonic fibroblasts is controlled by the activity of Tead family proteins and Myc.
    Mamada H; Sato T; Ota M; Sasaki H
    J Cell Sci; 2015 Feb; 128(4):790-803. PubMed ID: 25588835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet‑derived growth factor‑BB mediates pancreatic cancer malignancy via regulation of the Hippo/Yes‑associated protein signaling pathway.
    Li T; Guo T; Liu H; Jiang H; Wang Y
    Oncol Rep; 2021 Jan; 45(1):83-94. PubMed ID: 33416116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of Chromosome Instability by Activation of Yes-Associated Protein and Forkhead Box M1 in Liver Cancer.
    Weiler SME; Pinna F; Wolf T; Lutz T; Geldiyev A; Sticht C; Knaub M; Thomann S; Bissinger M; Wan S; Rössler S; Becker D; Gretz N; Lang H; Bergmann F; Ustiyan V; Kalin TV; Singer S; Lee JS; Marquardt JU; Schirmacher P; Kalinichenko VV; Breuhahn K
    Gastroenterology; 2017 Jun; 152(8):2037-2051.e22. PubMed ID: 28249813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Hippo pathway mediates inhibition of vascular smooth muscle cell proliferation by cAMP.
    Kimura TE; Duggirala A; Smith MC; White S; Sala-Newby GB; Newby AC; Bond M
    J Mol Cell Cardiol; 2016 Jan; 90():1-10. PubMed ID: 26625714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activity.
    Zucchini C; Manara MC; Cristalli C; Carrabotta M; Greco S; Pinca RS; Ferrari C; Landuzzi L; Pasello M; Lollini PL; Gambarotti M; Donati DM; Scotlandi K
    J Exp Clin Cancer Res; 2019 Dec; 38(1):503. PubMed ID: 31878963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hippo effector YAP directly regulates the expression of PD-L1 transcripts in EGFR-TKI-resistant lung adenocarcinoma.
    Lee BS; Park DI; Lee DH; Lee JE; Yeo MK; Park YH; Lim DS; Choi W; Lee DH; Yoo G; Kim HB; Kang D; Moon JY; Jung SS; Kim JO; Cho SY; Park HS; Chung C
    Biochem Biophys Res Commun; 2017 Sep; 491(2):493-499. PubMed ID: 28684311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma.
    Xu MZ; Chan SW; Liu AM; Wong KF; Fan ST; Chen J; Poon RT; Zender L; Lowe SW; Hong W; Luk JM
    Oncogene; 2011 Mar; 30(10):1229-40. PubMed ID: 21076472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway.
    Liu J; Li J; Li P; Wang Y; Liang Z; Jiang Y; Li J; Feng C; Wang R; Chen H; Zhou C; Zhang J; Yang J; Liu P
    Sci Rep; 2017 Feb; 7():42125. PubMed ID: 28169360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting the YAP-TEAD interaction interface for therapeutic intervention in glioblastoma.
    Saunders JT; Holmes B; Benavides-Serrato A; Kumar S; Nishimura RN; Gera J
    J Neurooncol; 2021 Apr; 152(2):217-231. PubMed ID: 33511508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of YAP suppresses CML cell proliferation and enhances efficacy of imatinib in vitro and in vivo.
    Li H; Huang Z; Gao M; Huang N; Luo Z; Shen H; Wang X; Wang T; Hu J; Feng W
    J Exp Clin Cancer Res; 2016 Sep; 35(1):134. PubMed ID: 27599610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metformin inhibits mTOR and c-Myc by decreasing YAP protein expression in OSCC cells.
    Wang Y; Zhang Y; Feng X; Tian H; Fu X; Gu W; Wen Y
    Oncol Rep; 2021 Mar; 45(3):1249-1260. PubMed ID: 33650651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Verteporfin inhibits proliferation, invasion and migration of MDA-MB-231 human breast cancer cells by down-regulating the expression of Yes-associated protein].
    Jiang Y; Liu Y; Zhang Z; Yang J; Ye X; Jin Q; Chen T
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Sep; 33(9):1223-1227. PubMed ID: 29089081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of Yes-Associated Protein by Verteporfin Ameliorates Unilateral Ureteral Obstruction-Induced Renal Tubulointerstitial Inflammation and Fibrosis.
    Jin J; Wang T; Park W; Li W; Kim W; Park SK; Kang KP
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33142952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Verteporfin exhibits YAP-independent anti-proliferative and cytotoxic effects in endometrial cancer cells.
    Dasari VR; Mazack V; Feng W; Nash J; Carey DJ; Gogoi R
    Oncotarget; 2017 Apr; 8(17):28628-28640. PubMed ID: 28404908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin Receptor and GPCR Crosstalk Stimulates YAP via PI3K and PKD in Pancreatic Cancer Cells.
    Hao F; Xu Q; Zhao Y; Stevens JV; Young SH; Sinnett-Smith J; Rozengurt E
    Mol Cancer Res; 2017 Jul; 15(7):929-941. PubMed ID: 28360038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. YAP Subcellular Localization and Hippo Pathway Transcriptome Analysis in Pediatric Hepatocellular Carcinoma.
    LaQuaglia MJ; Grijalva JL; Mueller KA; Perez-Atayde AR; Kim HB; Sadri-Vakili G; Vakili K
    Sci Rep; 2016 Sep; 6():30238. PubMed ID: 27605415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The TEAD Family and Its Oncogenic Role in Promoting Tumorigenesis.
    Zhou Y; Huang T; Cheng AS; Yu J; Kang W; To KF
    Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26805820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Verteporfin-induced formation of protein cross-linked oligomers and high molecular weight complexes is mediated by light and leads to cell toxicity.
    Konstantinou EK; Notomi S; Kosmidou C; Brodowska K; Al-Moujahed A; Nicolaou F; Tsoka P; Gragoudas E; Miller JW; Young LH; Vavvas DG
    Sci Rep; 2017 Apr; 7():46581. PubMed ID: 28429726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. XPO1-dependent nuclear export is a druggable vulnerability in KRAS-mutant lung cancer.
    Kim J; McMillan E; Kim HS; Venkateswaran N; Makkar G; Rodriguez-Canales J; Villalobos P; Neggers JE; Mendiratta S; Wei S; Landesman Y; Senapedis W; Baloglu E; Chow CB; Frink RE; Gao B; Roth M; Minna JD; Daelemans D; Wistuba II; Posner BA; Scaglioni PP; White MA
    Nature; 2016 Oct; 538(7623):114-117. PubMed ID: 27680702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.